sb 203580 has been researched along with magnolol in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (magnolol) | Trials (magnolol) | Recent Studies (post-2010) (magnolol) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 560 | 1 | 329 |
| Protein | Taxonomy | sb 203580 (IC50) | magnolol (IC50) |
|---|---|---|---|
| TPA: protein transporter TIM10 | Saccharomyces cerevisiae S288C | 68.3 | |
| high affinity choline transporter 1 isoform a | Homo sapiens (human) | 2.2952 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, WJ; Lee, SJ; Lee, US; Moon, SK; Park, SS | 1 |
1 other study(ies) available for sb 203580 and magnolol
| Article | Year |
|---|---|
Signaling pathway for TNF-alpha-induced MMP-9 expression: mediation through p38 MAP kinase, and inhibition by anti-cancer molecule magnolol in human urinary bladder cancer 5637 cells.
Topics: Antineoplastic Agents; Biphenyl Compounds; Cell Line, Tumor; Cell Movement; Enzyme Inhibitors; Humans; Imidazoles; Lignans; Matrix Metalloproteinase Inhibitors; NF-kappaB-Inducing Kinase; p38 Mitogen-Activated Protein Kinases; Protein Serine-Threonine Kinases; Pyridines; Signal Transduction; Tumor Necrosis Factor-alpha; Urinary Bladder Neoplasms | 2008 |